News
Keeping you up to date with the latest developments
News
HistologiX Showcase Expertise and Share Knowledge with New Resources Area on Website
Our Directors, Laboratory Managers, Study Directors and Research Scientists have in excess of 120 years of experience within Histology, Immunohistochemistry, Digital Pathology and Image Analysis. Our new resources area will showcase the latest insights, developments,...
HistologiX appoints new Managing Director to take company through ambitious growth plans
HistologiX, a leading Contract Research Organisation (CRO) offering Histology, IHC and Digital Pathology services, has appointed a new managing director to support its ambitious growth plans. The Nottingham-based company, which forms part of the Intelligent Tissue...
Advance your COVID-19 Research
Gain deeper insights into your COVID-19 research with our integrated package from Tissue Solutions and HistologiX. Read more.
COVID-19 Business Update – Lab Reopens
The main HistologiX Lab will reopen from 18th May following a detailed risk assessment.
Covid-19 Business Update
We would like to update our customers amid the ever-changing COVID-19 virus outbreak. To play our part in stopping the virus in its tracks, we have decided to temporarily close the main HistologiX Ltd. Lab from 25th March until further notice in line with the UK...
COVID-19 and business continuity
We would like to reassure you that it is business as usual and provide an update regarding our response to the outbreak of the COVID-19 virus as well as our commitment to serving you and your critically important work moving forward. Here are the measures that the...
Events
Oxford Global Biomarker Series US
Meet our team at the annual Biomarker Series US event on 15-16th Oct. Visit our virtual booth to speak to our exper
Oxford Global – Immuno Series UK
Meet our team at the annual Immuno Series event on 24-25th Aug. Learn about the latest research into the immune system and attend our presentation on single vs multiplex digital pathology assessment of immune “hot/cold” tumours in Non-Small Cell Lung Cancer (NSCLC). Find out more.
2020 BioNow Oncology Conference
The 2020 Bionow Oncology Conference will discuss the latest advances to address the current challenges facing cancer prevention and early diagnosis and translate the science into better care for cancer patients.